Expand DAWN Menu
DAWN MENU

DAWN Latest Press Releases

-- March 26, 2026 --

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN Business Wire 5:16 PM

-- March 12, 2026 --

Halper Sadeh LLC is Investigating Whether DAWN, SEM, EWCZ, FONR are Obtaining Fair Deals for their Shareholders Globe Newswire 3:49 PM
Are DAWN, TALK, UNF Obtaining Fair Deals for their Shareholders? PRNewswire 1:52 PM

-- March 11, 2026 --

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--DAWN, SEM, FONAR, and JHG PRNewswire 1:56 PM

-- March 10, 2026 --

Halper Sadeh LLC is Investigating Whether DAWN, KORE, CECO are Obtaining Fair Deals for their Shareholders Globe Newswire 11:51 AM

-- March 9, 2026 --

Are DAWN and TALK Obtaining Fair Deals for their Shareholders? PRNewswire 1:25 PM

-- March 6, 2026 --

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN Business Wire 6:25 PM
Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders PRNewswire 2:45 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) PRNewswire 1:12 PM
DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 10:34 AM
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio Globe Newswire 8:30 AM

-- February 24, 2026 --

Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance Globe Newswire 4:00 PM

-- February 10, 2026 --

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 Globe Newswire 8:30 AM

-- January 11, 2026 --

Day One Announces Preliminary 2025 OJEMDA Net Product Revenue And Provides 2026 Net Product Revenue Guidance Globe Newswire 5:00 PM

-- January 6, 2026 --

Day One Completes Acquisition of Mersana Therapeutics Globe Newswire 9:02 AM

-- December 16, 2025 --

Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:30 AM

-- November 24, 2025 --

Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting Globe Newswire 8:00 AM

-- November 18, 2025 --

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference Globe Newswire 8:30 AM

-- November 13, 2025 --

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases Globe Newswire 6:00 AM

-- November 10, 2025 --

Day One Announces New OJEMDA (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting Globe Newswire 7:00 AM

-- November 4, 2025 --

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress Globe Newswire 4:00 PM
Market Data Delayed 15 Minutes